Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Regular versus poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Read More »Antidepressant Use May Aid Outcomes in Depression and Diabetes
No Increase in Risk With Dapagliflozin in Patients With Stage 4 CKD
Prespecified analysis of RCT shows reduced risk with dapagliflozin versus placebo for composite outcome that included kidney, CV events
Read More »Cycling Linked to Reduced All-Cause, CVD Mortality in Diabetes
Multivariable-adjusted hazard ratios for all-cause mortality reduced for one to 59, 60 to 149, 150 to 299, and ≥300 minutes/week
Read More »Testosterone Therapy for Hypogonadism May Cut Risk for CV Events
Risk for myocardial infarction or stroke lower with testosterone therapy among men with hypogonadism and other cardiovascular risk factors
Read More »American Diabetes Association, June 25-29
Digital Self-Monitoring Effective for Weight Loss, Healthy Lifestyle
Finding significantly associated with tailored advice among adults with obesity, overweight
Read More »Glycemic Control Has Not Been Impacted by Pandemic
Despite drop in diabetes-related outpatient visits and testing, no negative association found with glycemic control
Read More »Glucose-Lowering Therapy Delayed for Newly Diagnosed T2DM Patients
Factors in therapeutic inertia examined in adults newly diagnosed with T2DM receiving primary care in the U.K.
Read More »Gestational Diabetes May Increase Risk for Fetal Hypoxia
Hypoxia-related ZigZag pattern, late decelerations of FHR on intrapartal CTG and increased risk of fetal asphyxia seen in GDM pregnancies
Read More »Medication Type for T2DM May Affect Severe COVID-19 Outcomes
Premorbid GLP1-RA use, SGLT2i use associated with lower 60-day mortality compared to premorbid DPP4i use
Read More »